Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Fuji
AstraZeneca
Healthtrust
Argus Health

Generated: September 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,447,089

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,447,089 protect, and when does it expire?

Patent 9,447,089 protects ZELBORAF and is included in one NDA.

This patent has sixty-three patent family members in thirty-nine countries.

Summary for Patent: 9,447,089
Title:Compositions and uses thereof
Abstract: Provided are solid dispersions, solid molecular complexes, salts and crystalline polymorphs involving propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluor- o-phenyl}-amide.
Inventor(s): Desai; Dipen (Whippany, NJ), Diodone; Ralph (Breisach, DE), Go; Zenaida (Clifton, NJ), Ibrahim; Prabha N. (Mountain View, CA), Iyer; Raman (Piscataway, NJ), Mair; Hans-Juergen (Loerrach, DE), Sandhu; Harpreet K. (West Orange, NJ), Shah; Navnit H. (Clifton, NJ), Visor; Gary (Castro Valley, CA), Wyttenbach; Nicole (Sissach, CH), Lauper; Stephan (Kaiseraugst, CH), Pudewell; Johannes (Oberwil, CH), Wierschem; Frank (Rheinfelden, CH)
Assignee: Plexxikon Inc. (Berkeley, CA) Hoffman-La Roche Inc. (Nutley, NJ)
Application Number:12/752,035
Patent Claim Types:
see list of patent claims
Compound; Formulation; Dosage form; Composition;

Drugs Protected by US Patent 9,447,089

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Hoffmann La Roche ZELBORAF vemurafenib TABLET;ORAL 202429-001 Aug 17, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,447,089

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
09175665Nov 11, 2009

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Covington
Colorcon
Medtronic
Queensland Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.